Abstract

Commenting on our article on the emergency reduction of blood pressure (September 24, 1971 p. 80) Allen & Hanburys, the manufacturers of diazoxide, have asked us to point out that their trade-name Eudemine applies only to the oral form. They supply the solution for intravenous injection only for clinical trial in hypertensive emergencies (except in eclampsia or pre-eclampsia). How-ever, recent evidence suggests that oral diazoxide may be a useful adjunct to intravenous diazoxide in severe hypertension associated with renal failure.¹